Up a level |
Armando, M; Schneider, M; Pontillo, M; Vicari, S; Debbané, M; Schultze-Lutter, F; Eliez, S (2017). No age effect in the prevalence and clinical significance of ultra-high risk symptoms and criteria for psychosis in 22q11 deletion syndrome: Confirmation of the genetically driven risk for psychosis? PLoS ONE, 12(4), e0174797. Public Library of Science 10.1371/journal.pone.0174797
Michel, C; Toffel, E; Schmidt, SJ; Eliez, S; Armando, M; Solida-Tozzi, A; Schultze-Lutter, F; Debbané, M (2017). [Detection and early treatment of subjects at high risk of clinical psychosis: Definitions and recommendations]. L'Encéphale, 43(3), pp. 292-297. Elsevier 10.1016/j.encep.2017.01.005
Schneider, M; Armando, M; Pontillo, M; Vicari, S; Debbané, M; Eliez, S; Schultze-Lutter, F (2016). Ultra high risk status and transition to psychosis in 22q11.2 deletion syndrome. World psychiatry, 15(3), pp. 259-265. Wiley 10.1002/wps.20347
Armando, M; Schneider, M; Pontillo, M; Vicari, S; Debbané, M; Schultze-Lutter, F; Eliez, S (2016). Age matters in the prevalence and clinical significance of ultra-high-risk for psychosis symptoms and criteria in 22q11 Deletion Syndrome. Early intervention in psychiatry, 10(S1), p. 120. Blackwell Publishing Asia
Schneider, M; Armando, M; Pontillo, M; Vicari, S; Debbane, M; Schultze-Lutter, F; Eliez, S (2016). Ultra high-risk status and transition to psychosis in 22q11.2 deletion syndrome. Early intervention in psychiatry, 10(S1), p. 168. Blackwell Publishing Asia